Evolocumab in STEMI

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

December 5, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
ST Elevation Myocardial Infarction
Interventions
DRUG

Repatha®

Repatha® 140mg x 3 pens subcutaneous injection

Trial Locations (1)

14574

Sejong General Hospital, Bucheon-si

All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

National Health Insurance Service Ilsan Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Daegu Catholic University Medical Center

OTHER

collaborator

Catholic University of Korea Eunpyeong St. Mary's Hospital

UNKNOWN

lead

Sejong General Hospital

OTHER

NCT06081803 - Evolocumab in STEMI | Biotech Hunter | Biotech Hunter